Buprenorphine in the Treatment of Opioid Dependence

Psychiatric Comorbidity

American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition Text Revision (DSM-IV-TR). Washington, DC: American Psychiatric Association, 2000.

American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. Fourth Edition. Washington, DC: American Psychiatric Association, 1994.

Beck AT, Ward CH, Mendelson M, Mock J, and Erbaugh J. An inventory for measuring depression. Archives of General Psychiatry (4):53–63, 1961.

Brooner RK, King VL, Kidorf MS, Schmidt CW, and Bigelow GE. Psychiatric and substance use comorbidity among treatment-seeking opioid abusers. Archives of General Psychiatry (54):71–80, 1997.

Costa PT and McCrae RR. The NEO Personality Inventory Manual. Odessa, FL: Psychological Assessment Resources, 1985.

First MB, Spitzer RL, Gibbon M, and Williams JBW. Structured Clinical Interview for DSM-IV Axis I Disorders, Patient Edition (SCID-I/P, Version 2.0). New York: Biometrics Research Department, New York State Psychiatric Institute, 1995.

Khantzian EJ and Treece C. DSM-III psychiatric diagnosis of narcotic addicts. Archives of General Psychiatry (42):1,067–1,071, 1985.

King VL, Brooner RK, Kidorf MS, Stoller KB, and Mirsky AF. Attention deficit hyperactivity disorder and treatment outcome in opioid abusers entering treatment. Journal of Nervous Mental Disorders (187):487–495, 1999.

Kosten TR, Morgan C, and Kosten TA. Depressive symptoms during buprenorphine treatment of opioid abusers. Journal of Substance Abuse Treatment (7):51–54, 1990.

Kosten TR, Rounsaville BJ, and Kleber H. A 2.5-year follow-up of cocaine use among treated opioid addicts: Have our treatments helped? Archives of General Psychiatry (44):281–284, 1987.

Levin FR, Evans SM, and Kleber HD. Prevalence of adult attention-deficit hyperactivity disorder among cocaine abusers seeking treatment. Drug and Alcohol Dependence (52):15–25, 1998.

Nunes EV, Quitkin FM, Donovan SJ, Deliyannides D, Ocepek-Welikson K, Koenig T, Brady R, McGrath PJ, and Woody GE. Imipramine treatment of opiate-dependent patients with depressive disorders. Archives of General Psychiatry (55):153–160, 1998.

Reiger DA, Farmer ME, Rae DS, Locke BZ, Keith SJ, Judd LL, and Goodwin FK. Co-morbidities of mental disorders with alcohol and other drug abuse. Journal of the American Medical Association (264):2,511–2,518, 1990.

Robins LN, Helzer JE, Weissman MM, Orvaschel H, Gruenberg E, Burke JD, and Regier DA. Prevalence of specific psychiatric disorders in three sites. Archives of General Psychiatry (41):949–958, 1984.

Rounsaville BJ, Anton SF, Carroll K, Budde D, Prusoff BA, and Gawin F. Psychiatric diagnoses of treatment-seeking cocaine abusers. Archives of General Psychiatry (48):43–51, 1991.

Rounsaville BJ, Kosten TR, Weissman MM, and Kleber H. Prognostic significance of psychopathology in treated opioid addicts: A 2.5-year follow-up study. Archives of General Psychiatry (43):739–735, 1986.

Rounsaville BJ, Weissman MM, Crits-Christoph K, Wilber C, and Kleber H. Diagnosis and symptoms of depression in opioid addicts. Archives of General Psychiatry (39):151–156, 1982.

Rounsaville BJ, Weissman MM, Kleber HD, and Wilber C. Heterogeneity of psychiatric diagnosis in treated opiate addicts. Archives of General Psychiatry (39):161–166, 1982.

Spitzer RL, Kroenke K, and Williams JBW. Utility of a new procedure for diagnosing mental disorders in primary care: The PRIME-MD 1000 study. Journal of the American Medical Association (272):1,749–1,756, 1994.

Veterans Health Administration, Substance Use Disorders Workgroup. VHA Clinical Practice Guideline Management of Persons With Substance Use Disorders, Version 1. Washington, DC: Veterans Health Administration, 1999.

Woody GE, McLellan AT, Luborsky L, and O'Brien CP. Sociopathy and psychotherapy outcome. Archives of General Psychiatry (42):1,081–1,086, 1985.

Woody GE, O'Brien CP, and Rickels K. Depression and anxiety in opioid addicts: A placebo-controlled study of doxepin in combination with methadone. American Journal of Psychiatry (132):447–450, 1975.